Abstractive Health vs Credo Health (2026)
Both retrieve the outside record and both summarise it, and they are honest about different halves of the same problem. Credo is honest about coverage: Care Map tells you which records should exist and have not arrived, which is the failure mode every other product in this category quietly absorbs by summarising whatever it happened to receive. Abstractive is honest about quality: it published its own evaluation in a peer reviewed journal and reported that its summaries were marginally inferior to physicians on usefulness and safety, then linked every sentence of every summary to its source note so a clinician can check the specific claim. Abstractive is the stronger record overall, with a complete compliance stack and published prices against a vendor with no attestation and no rate. Credo retrieves harder, including by hand.
- Sentence level provenance, with every line of a summary linked to the source note behind it, plus a peer reviewed evaluation published in a major journal whose headline finding was unfavourable to the vendor's own product.
- The compliance stack is complete: SOC 2 Type II for the company itself, a public trust centre, a published business associate agreement, and a published price ladder with a free tier, which is close to unheard of in products sold to health systems.
- It is a direct implementer on the national exchange framework rather than a consumer of someone else's connection, which is the deepest interoperability position in this category.
- Care Map names the gap. It maps where records should exist and reports what has not been retrieved, so a clinician knows the history is incomplete instead of assuming it is not.
- Three national networks are named rather than two, alongside regional exchanges and a manual retrieval path for records the networks do not return, which is the difference between most of a history and the whole of it.
- The workflow is pre encounter rather than in encounter, delivering the history, risk analysis and quality gap closure before the visit starts, which is when the information can still change what happens.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abstractive Health and Credo Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abstractive Health | Credo Health |
|---|---|---|
| Primary category | Clinical Summarization & Chart Review | Clinical Summarization & Chart Review |
| Founded | 2022 | Not recorded |
| Headquarters | New York, NY, US | Denver, CO, US |
| Website | abstractivehealth.com | credohealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Abstractive Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Credo Health, Abstractive Health grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Credo Health its top capability grade on EHR and Interoperability Depth. Set against Abstractive Health, Credo Health does not grade higher on any scored axis, though the two are level on several axes, including FDA and Regulatory Status, EHR and Interoperability Depth and Deployment Model and Data Residency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Abstractive Health or Credo Health?
The AI Health Index grades Abstractive Health higher than Credo Health on every axis that separates them, several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Credo Health does not grade higher on any scored axis.
Where do Abstractive Health and Credo Health differ most?
The widest separation the AI Health Index records between Abstractive Health and Credo Health is on Model and Technology Transparency, where Abstractive Health grades A and Credo Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Abstractive Health and Credo Health grade the same?
The AI Health Index grades Abstractive Health and Credo Health the same on several axes, including FDA and Regulatory Status, EHR and Interoperability Depth and Deployment Model and Data Residency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
Credo publishes no security attestation, trust centre or report request path, no retention period, no training use statement and no de identification posture, which is a wide disclosure gap for a product that assembles records from many organisations. Its pitch to value based care buyers includes more complete risk adjustment, so the same retrieval that improves clinical context also raises reimbursement, and a buyer should ask which effect is being measured.
Abstractive Health has named itself into a regulatory category it has not addressed, with no clearance, authorisation, pathway statement or exemption analysis located, and it offers hosted software only with no customer hosted option.